Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 76282-448

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 76282-448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 10/12.5 mg (90 tablets)

Lisinopril and Hydrochlorothiazide Tablets, USP is a medicine for which the usual dosage is mentioned in the accompanying prescribing information. It contains 10mg of lisinopril, USP and 12.5mg of hydrochlorothiazide, USP. It should be stored at a temperature of 20° to 25°C and should be protected from excessive light and humidity. Additionally, it should be dispensed in a container that is resistant to light and has a child-resistant closure. This medicine is manufactured by InvaGen Pharmaceuticals, Inc and is a subsidiary of Cipla Ltd. The medicine is manufactured for Exelan Pharmaceuticals, Inc.*

FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/12.5 mg (90 tablets)

This is a description of a medication called Lisinopril and Hydrochlorothiazide Tablets, USP by Exelan Pharmaceuticals. It comes in a container of 90 tablets with each tablet containing 20 mg of lisinopril, USP and 12.5 mg of hydrochlorothiazide, USP. The usual dosage can be found in the accompanying prescribing information. The medication should be stored at 20° to 25°C (68° to 77°F) and protected from excessive light and humidity. It should also be kept out of the reach of children and dispensed in a tight, light-resistant container with a child-resistant closure. The medicine is manufactured by InvaGen Pharmaceuticals, Inc. and distributed by Exelan Pharmaceuticals, Inc.*

FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/25 mg (90 tablets)

This is a description of Lisinopril and Hydrochlorothiazide tablets. Each tablet contains 20 mg of lisinopril and 25 mg of hydrochlorothiazide. The usual dosage information is provided in the accompanying prescribing information. The tablets should be stored at room temperature and protected from excessive light and humidity. The medication should be kept out of the reach of children and dispensed in a tight, light-resistant container. The tablets are manufactured by InvaGen Pharmaceuticals and distributed by Exelan Pharmaceuticals.*

FDA Label Image

Structural Formula 1 (Image 01)

FDA Label Image

Structural Formula 2 (Image 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.